UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

JNCI : Journal of the National Cancer Institute, 2010-07, Vol.102 (13), p.950-958

2010

Volltextzugriff (PDF)

Prostate cancer: ESMO Consensus Conference Guidelines 2012

Annals of oncology, 2013-05, Vol.24 (5), p.1141-1162

2013

Volltextzugriff (PDF)

Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial

The Journal of urology, 2022-11, Vol.208 (5), p.1018-1027

2022

Volltextzugriff (PDF)

Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data

JNCI : Journal of the National Cancer Institute, 2015-01, Vol.107 (1), p.366-366

2015

Volltextzugriff (PDF)

Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial

Hernia : the journal of hernias and abdominal wall surgery, 2022-02, Vol.26 (1), p.157-164

2022

Volltextzugriff (PDF)

The value of systematic biopsies in screening for prostate cancer with PSA followed by MRI – results from the GÖTEBORG prostate cancer screening 2 trial

EUROPEAN UROLOGY, 2022, Vol.81, p.S565

2022

Volltextzugriff (PDF)

Lymph swelling after radical prostatectomy and pelvic lymph node dissection

EUROPEAN UROLOGY, 2022, Vol.81, p.S1699-S1700

2022

Volltextzugriff (PDF)

Correction: Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial

Hernia : the journal of hernias and abdominal wall surgery, 2022-04, Vol.26 (2), p.683-683

2022

Volltextzugriff (PDF)

Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey

World journal of urology, 2020-06, Vol.38 (6), p.1397-1411

2020

Volltextzugriff (PDF)

Salvage radiation therapy in prostate cancer: relationship between rectal dose and long-term, self-reported rectal bleeding

Clinical & translational oncology, 2021-02, Vol.23 (2), p.397-404

2021

Volltextzugriff (PDF)

Hospital readmissions after limited vs. extended lymph node dissection during open and robot-assisted radical prostatectomy

Urologic oncology, 2020-01, Vol.38 (1), p.5.e1-5.e8

2020

Volltextzugriff (PDF)

Three‐month neoadjuvant hormonal therapy before radical prostatectomy: a 7‐year follow‐up of a randomized controlled trial

BJU international, 2002-10, Vol.90 (6), p.561-566

2002

Volltextzugriff (PDF)

Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts

The Journal of urology, 2017, Vol.197 (1), p.90-96

2017

Volltextzugriff (PDF)

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO

European urology open science (Online), 2020-07, Vol.20, p.54-61

2020

Volltextzugriff (PDF)

Editorial Comment: A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

International Brazilian journal of urology, 2020-05, Vol.46 (3), p.465-466

2020

Volltextzugriff (PDF)

Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial

European urology, 2015-08, Vol.68 (2), p.216-225

2015

Volltextzugriff (PDF)

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual

British journal of cancer, 2012-08, Vol.107 (5), p.778-784

2012

Volltextzugriff (PDF)

Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC)

Progrès en urologie (Paris), 2020-04, Vol.30 (5), p.252-260

2020

Volltextzugriff (PDF)

Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer

European journal of cancer (1990), 2010-11, Vol.46 (17), p.3068-3072

2010

Volltextzugriff (PDF)

Change of tumour characteristics and treatment over time in both arms of the European Randomized study of Screening for Prostate Cancer

European journal of cancer (1990), 2010-11, Vol.46 (17), p.3082-3089

2010

Volltextzugriff (PDF)

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

The New England journal of medicine, 2022-12, Vol.387 (23), p.2126-2137

2022

Volltextzugriff (PDF)

25-year outcomes for men on active surveillance after screen detected prostate cancer in the Göteborg-1 trial

European urology, 2024-03, Vol.85, p.S1836-S1837

2024

Volltextzugriff (PDF)

A0825 - 25-year outcomes for men on active surveillance after screen detected prostate cancer in the Göteborg-1 trial

European urology, 2024-03, Vol.85, p.S1836-S1837

2024

Volltextzugriff (PDF)

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

Prostate cancer and prostatic diseases, 2018-06, Vol.21 (2), p.228-237

2018

Volltextzugriff (PDF)

Long-term Effects on Quality of Life After Treatment of Localized Prostate Cancer: A Comparison of 4 Different Treatment Modalities

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S406-S406

2012

Volltextzugriff (PDF)

1 – 25 von 409

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(302)
Mit Volltextzugriff
(330)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

Prostate cancer: ESMO Consensus Conference Guidelines 2012

Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial

Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data

Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial

The value of systematic biopsies in screening for prostate cancer with PSA followed by MRI – results from the GÖTEBORG prostate cancer screening 2 trial

Lymph swelling after radical prostatectomy and pelvic lymph node dissection

Correction: Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial

Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey

Salvage radiation therapy in prostate cancer: relationship between rectal dose and long-term, self-reported rectal bleeding

Hospital readmissions after limited vs. extended lymph node dissection during open and robot-assisted radical prostatectomy

Three‐month neoadjuvant hormonal therapy before radical prostatectomy: a 7‐year follow‐up of a randomized controlled trial

Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO

Editorial Comment: A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual

Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC)

Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer

Change of tumour characteristics and treatment over time in both arms of the European Randomized study of Screening for Prostate Cancer

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

25-year outcomes for men on active surveillance after screen detected prostate cancer in the Göteborg-1 trial

A0825 - 25-year outcomes for men on active surveillance after screen detected prostate cancer in the Göteborg-1 trial

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

Long-term Effects on Quality of Life After Treatment of Localized Prostate Cancer: A Comparison of 4 Different Treatment Modalities

Suchergebnisse filtern